Journal criticises Vioxx study for omitting three heart attacks

BMJ 2005; 331 doi: (Published 15 December 2005) Cite this as: BMJ 2005;331:1423
  1. Janice Hopkins Tanne
  1. New York

    The New England Journal of Medicine has issued an editorial “statement of concern” about the omission of data in a paper it published. It said that three heart attacks were omitted from a study comparing rofecoxib (Vioxx) with naproxen, under-stating the risks of rofecoxib.

    The editorial by the journal's three top editors will appear in print in the 29 December issue but was published online on 8 December (, doi: 10.1056/NEJMe058314).

    It said: “Relevant data on cardiovascular outcomes had been deleted from the VIGOR [Vioxx gastrointestinal outcomes research] manuscript prior to its submission to the journal and… the authors had withheld data on other relevant cardiovascular outcomes. …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription